A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial

Objective: To study the immunogenicity and reactogenicity of a combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine (Hib-MenC-TT) when administered as a booster dose in combination with a measles, mumps and rubella vaccine (MMR). Design: A ph...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Pace, D, Snape, M, Westcar, S, Oluwalana, C, Yu, L, Begg, N, Wysocki, J, Czajka, H, Maechler, G, Boutriau, D, Pollard, A
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: BMJ Publishing Group 2008
Aiheet: